Main > ENDOCRINOLOGY > Diabetes. Treatment > VildaGliptin (DPP-IV Inhibitor) > Co.: CH. N. (EU Approved/Patents)

---

Co.: CH. N. (EU Approved/Patents)'s subsections
Company
DPP = DiPeptidyl Peptidase
Patent>DisClosure
Patent>UpDate: 01.30.07
Patent>US Expiration: 12.09.2019
Structural IUPAC Name
TradeMark
Type 2 Diabetes
UpDate: 02.01.2008. (PR)
USA>Status>

Co.: CH. N. (EU Approved/Patents)'s products
This section has no products